Guidant’s $3 Bil. Cook Purchase Hinges On Ownership Of Subsidiary, Data

Guidant's $3 bil. purchase of Cook Group does not represent a "change of ownership" under the terms of a 1997 licensing agreement between subsidiary Cook, Inc., Angiotech Pharmaceuticals and Boston Scientific, Guidant asserts